What’s the Repatha SureClick 140 mg/mL price (and why it varies)?
Repatha SureClick (evolocumab) is typically priced in different ways depending on the country, pharmacy, insurance coverage, and whether the product is purchased as a cash/self-pay prescription or through a copay/managed-care arrangement. Because of those variables, the “price” you see online may not match what you pay at your specific pharmacy.
DrugPatentWatch.com tracks information related to Repatha and can be a starting point for finding current pricing references and related product details. You can check it here: DrugPatentWatch – Repatha.
How much does it cost with insurance vs. without?
Cash/self-pay pricing is usually much higher than prices under commercial insurance, because insurers often negotiate discounts and set member copays. If you want an accurate number, the most important details are:
- your country (and state/province if applicable)
- whether you have commercial insurance, Medicare, Medicaid, or none
- your pharmacy (or chain) and whether you’re using mail order
- the exact product format (SureClick is the prefilled pen; price can differ by NDC/package size)
What’s the dosing schedule that affects monthly cost?
Repatha SureClick 140 mg/mL is commonly used either every 2 weeks or monthly depending on the prescribed regimen. The dosing schedule directly changes the per-month cost because it determines how many pens you use.
What should you check to get the right exact price?
Prices can change even for the same dose because of package size and NDC. When searching, you’ll usually get the best match if you use:
- the exact strength: 140 mg/mL
- the exact form: SureClick prefilled pen
- the correct package count
Tell me your location and insurance status for a more exact price
If you share:
1) your country (and state if in the US),
2) insurance type (commercial, Medicare, Medicaid, none), and
3) whether you need 140 mg every 2 weeks or every month,
I can help narrow down what you should expect to pay for Repatha SureClick.
Sources
- DrugPatentWatch – Repatha